Greenphire To Tackle Critical Topics Impacting Patient Experience and Retention at Leading European Clinical Trial Industry Events in November

Executives to speak at Clinical Trials Europe and the SCRS European Site Solutions Summit; Greenphire will also attend Clinical Operations in Oncology Trials Europe 2022

 King of Prussia, PA – Greenphire, the global leader in financial lifecycle management for clinical trials, today announced its participation in three key European industry events taking place in November. Greenphire executives will speak at Clinical Trials Europe and SCRS European Site Solutions Summit and will also attend Clinical Operations in Oncology Trials Europe 2022. Topics that will be addressed include the next-gen patient experience, innovations around patient recruitment and retention in oncology research and more.  

Clinical Trials Europe

November 7-9, 2022, at the RAI Amsterdam Convention Center in Amsterdam, Netherlands

Kyle Cunningham, Chief Product Officer at Greenphire

During Cunningham’s session “Shaping The Next Gen Participant Experience,” on November 8th, he will discuss key drivers of digital transformation within the patient journey, how technology can enable a more positive experience for study participants, improving the patient experience without hurting the site experience and more.

The SCRS European Site Solutions Summit

November 14-15, 2022, at the Hotel Cascais Miragem in Lisbon, Portugal

Graham Howieson, Senior Director of Business Development for Europe at Greenphire

Howieson will participate in two separate panels. The first, “Innovative Methods for Patient Recruitment & Retention in Oncology Research,” will take place on Monday, November 14th and focus on oncology clinical trial referral and recruitment. Alongside experts from Pfizer, MSD and others, Howieson will discuss best practices for building and expanding a successful patient experience.  

The second panel “Breaking (Further) into Decentralized Clinical Trials (DCT),” will take place on November 15th. Alongside panelists, Howieson will take a deeper dive into DCTs, and discuss operational blueprints to run effective DCT trials.

Clinical Operations in Oncology Trials Europe 2022

Greenphire will also attend Clinical Operations in Oncology Trials Europe 2022 taking place November 22-23, 2022 at the Mövenpick Hotel Zürich-Regensdorf, Zurich, Switzerland. 

“Patients are the number one component to any trial. It’s critical we continue to evolve the patient experience to keep them engaged and active. A recent Market Trends Survey we conducted showed that 95 percent of sponsors and CROs agree that providing tech solutions for patient engagement in clinical trials can positively impact recruitment and retention,” said Cunningham. “The heart and soul of our solutions are ensuring that patients have a positive experience and that a trial can run seamlessly. We’re thrilled to be selected to speak at Clinical Trials Europe and the SCRS European Site Solutions Summit.”

To learn more about Greenphire, book a demo here. 

About Greenphire

Greenphire is the leader in global clinical trial financial process automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s EnvisiXTM, eClinicalGPS®, ClinCard® and ConneX® solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.